Description
The goal of this study is to further characterise the potential long-term safety risks of lonapegsomatropin in patients treated with lonapegsomatropin under real-world conditions in the post-marketing setting.
Location: SIMR (Sacramento/Valley Area)
Please contact: SIMR@sutterhealth.org about SkyPass
Principal Investigator
Related Studies
A Patient-Centered Strategy for Improving Diabetes Prevention in Urban American Indians.
Managing Cardiometabolic Disease in Primary Care
Investigators: J.B. Jones, PhD, MBA, Xiaowei (Sherry) Yan, PhD, MS
Culturally Adapted DPP [Diabetes Prevention Program] Intervention for Mexican Americans in Primary Care: An RCT [randomized controlled trial]
Research Aimed at Improving Both Mood and Weight (RAINBOW)
Strength Training Regimen for Normal Weight Diabetics (STRONG-D) Study
New Weigh of Life Program Evaluation
eCMP (electronic Cardiometabolic Program)
Investigator: Kristen M.J. Azar, R.N., BSN, MSN/MPH
Evaluation of Chronic Care Transformation at PAMF
Investigator: Cheryl Stults, Ph.D.